DocGo Inc.

DocGo Inc.

DCGONYSE / NASDAQHealthcareSmall cap

$0.17+$0.00 (+1.7%)

Last close · Data as of Nov 20, 2026

Market cap
$56.3M
P/E
-0.3x
EV / EBITDA
-0.5x
Revenue
$322.2M
Net margin
-56.6%
ROCE
-59.6%

-80.0% over the last year

DocGo Inc. price, 1Y

Daily closes.

Go deeper

Technical chart: candles, 28 indicators including moving averages, RSI and MACD, drawing tools and five colour themes

Open technical chart
Open technical chartCandles, 28 indicators, drawing tools

Performance

Price return, before dividends, to the 20 Nov 2026 close.

1M
-32.4%
3M
-59.3%
6M
-71.5%
1Y
-80.0%
5Y
-98.2%

52-week range

Day change +$0.00 (+1.7%) from $0.17 to $0.17 · Last close Nov 20, 2026

Best weekday to invest, historically

The same weekly amount in DCGO, bought on each weekday since 2021.

News & filings

What DocGo filed, who traded, and what's next

How to read this

"News & filings" lists what the company itself has put on record with regulators, who inside it traded, the news that names it, and the next date we know of. Filings and releases are first-hand; news is third-party and may be thin for smaller companies. A day of insider filings is one row. Nothing here is a recommendation.

AI Summary

US Stock

ConcernThe company made a net loss of 182 million US dollars in fiscal 2025.

Strengths (1)

  • Free cash flow in fiscal 2025 equals 48.0% of the company's market value.

Prices to the 20 Nov 2026 close · Financial year: fiscal 2025

Rule-based from financial data. Not advice.

About the company

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services.

Read moreShow less

DocGo Inc. operates as a mobile healthcare services company in the United States and the United Kingdom. It operates through Mobile Health Services and Transportation Services segments. The company offers transportation services comprising emergency response services; and non-emergency transport services, such as ambulance and wheelchair transportation services. It also provides mobile health services through its care delivery platform that are performed at home, offices, and other locations comprising mobile urgent care, exams, vaccinations, monitoring and care management, procedures, point-of-care tests, and screenings and coaching; event services, including on-site healthcare support at sporting events and concerts; virtual care management; and remote patient monitoring and chronic disease management services. The company serves municipalities, hospitals and health systems, states and communities, insurers, physician practices, health plans, and businesses and employees. DocGo Inc. was founded in 2015 and is headquartered in New York, New York.

Sector
Healthcare
Shares outstanding
98.6M

Valuation, profitability, growth and solvency at the latest close; hover a label for its meaning.

Valuation

Market cap
$56.3M
P/E
-0.3x
P/B
0.4x
EV / EBITDA
-0.5x
EV / Sales
0.1x
P/S
0.2x
52-week high
$1.08
52-week low
$0.17

Profitability

Operating margin
-27.7%
Net margin
-56.6%
EBITDA margin
-22.8%
ROE
-126.7%
ROCE
-59.6%
ROIC
-67.7%
ROA
-84.0%
Asset turnover
1.48

Growth

Revenue
$322.2M
Revenue growth, 1Y
-47.7%
Revenue CAGR, 3Y
-9.9%
Net profit growth, 1Y
-1012.4%
Free cash flow
$27.0M

Solvency

Current ratio
2.26
Debt / Equity
0.20
Debt / Assets
0.13
CFO / Net profit
-0.19
Cash / Market cap
90.6%

Where the revenue went

FY2025 ended in a loss, so the lines are listed rather than drawn as a flow.

LineFY2025
Revenue$322.2M
Cost of revenue$223.4M
Gross profit$98.8M
Operating expenses$187.9M
Research and development$13.6M
Selling, general and administrative$158.7M
Operating income-$89.2M
Interest and other-$98.3M
Pretax income-$187.5M
Tax and other-$5.1M
Net income-$182.4M

Revenue and net profit

Revenue fell 47.7% in FY2025; net profit is the dashed line.

DocGo Inc. revenue and net profit by fiscal year
DocGo Inc. revenue and net profit by fiscal year
DateRevenueNet profit
FY2022$440.5M$34.6M
FY2023$624.3M$6.9M
FY2024$616.6M$20.0M
FY2025$322.2M-$182.4M

Cash flows

FY2025: $34.5M from operations, $27.0M free after investment (dashed).

DocGo Inc. operating and free cash flow by fiscal year
DocGo Inc. operating and free cash flow by fiscal year
DateOperating cash flowFree cash flow
FY2022$28.9M$23.4M
FY2023-$64.5M-$74.3M
FY2024$70.1M$64.5M
FY2025$34.5M$27.0M

Growth

Latest fiscal year 2025: each figure with its change over the year before.

Revenue
$322.2M-47.7%1Y
EBITDA
-$73.5M-264.9%1Y
Net profit
-$182.4M-1,012.4%1Y
Cash from operations
$34.5M-50.9%1Y
Free cash flow
$27.0M-58.1%1Y
Revenue CAGR, 3Y
-9.9%
YearRevenueEBITDANet profitFCFROERevenue growth 1YNet profit growth 1Y
FY2025$322.2M-$73.5M-$182.4M$27.0M-126.7%-47.7%-1012.4%

Monthly returns

Month-by-month returns of DCGO across the years, with the seasonal pattern.

Balance sheet

What the company owns and owes at the end of FY2025.

LineFY2025
Assets$217.1M
Liabilities$91.2M
Equity$125.9M
Paid-in capital$325.4M
Retained earnings-$183.8M
Minority interest-$18.1M

Market cap against peers

8 peers: same sector, nearest by size.

Peers map

Healthcare companies placed by value, growth and quality; DCGO highlighted.

P/E against peers

Most of this group is loss-making, so EV / Sales is compared for the companies without a P/E.

No company in this group has a positive P/E.

EV / Sales, for the companies without earnings

  1. DocGo Inc. (this company)0.1x

Not shown (no positive earnings and no EV / Sales): Actuate Therapeutics, Inc. Common stock, Tevogen Bio Holdings Inc.

Peer comparison

Same-sector peers by market cap, with the median.

CompanyMarket capP/EP/BROEEV/EBITDA
DocGo Inc.DCGOthis company$56.3M-0.3x0.4x-126.7%-0.5x
Pulmonx CorporationLUNG$68.4M—1.3x-99.8%—
LENSAR, Inc.LNSR$68.0M-2.0x-2.6x131.7%-2.9x
aTyr Pharma, Inc.ATYR$50.3M-0.7x0.7x-109.8%-0.7x
Myomo, Inc.MYO$49.8M-3.2x4.4x-136.6%-4.4x
Actuate Therapeutics, Inc. Common stockACTU$46.4M-2.1x5.9x-280.5%—
Accuray IncorporatedARAY$43.5M-27.3x0.5x-2.0%8.0x
Gossamer Bio, Inc.GOSS$41.7M-0.2x-0.3x138.8%-1.3x
Tevogen Bio Holdings Inc.TVGN$41.3M-1.6x-2.4x154.2%-1.9x
Peer median—-2.0x0.6x-50.9%-1.6x

Year-to-date ROI

DCGO since 1 January, against earlier years.

Historical volatility

DCGO's day-to-day swings over 30, 60 and 180 days.

Financial statements

Income statement, balance sheet and cash flow as reported, grouped into plain-language lines.

Consolidated figures in USD, fiscal years, newest first.

Operating margin by fiscal year

DocGo Inc. operating margin by fiscal year
DocGo Inc. operating margin by fiscal year
DateOperating margin
FY20225.0%
FY20232.4%
FY20244.7%
FY2025-27.7%
LineFY2025
Cost of revenueCost Of Revenue$223.4M
Gross profitGross Profit$98.8M
Operating expensesOperating Expense$187.9M
Research and developmentResearch And Development$13.6M
Depreciation and amortisationDepreciation And Amortization In Income Statement$15.7M
Depreciation, amortisation and depletionDepreciation Amortization Depletion Income Statement$15.7M
Total expensesTotal Expenses$411.4M
Pretax incomePretax Income-$187.5M

Learn while you research

Academy chapters picked for DocGo Inc. and the metrics on this page.

  1. 01 Stock Valuation BasicsHow to think about what a fair price for a stock looks like.7 min read
  2. 02 Stock Market RisksSmall caps carry concentrated, idiosyncratic risk, learn to manage it.6 min read
  3. 03 Sector Analysis MattersHealthcare valuation is driven by pipelines and regulation, not just numbers.6 min read
  4. 04 Essential Stock RatiosP/E, P/B, EV/EBITDA, what they mean and when to use each.7 min read
  5. 05 How to Read a Cash-Flow StatementProfit can be manipulated; cash flow rarely lies.7 min read
Browse the full Equiscale Academy →